Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bal 5788
2. Bal-5788
3. Bal5788
4. Ceftobiprole Medocaril (inn)
5. Ceftobiprole Medocaril Free Acid
6. Ceftobiprole Medocaril Sodium
1. 252188-71-9
2. Unii-n99027v28j
3. Ceftobiprole Medocaril (sodium)
4. Bal5788
5. Ceftobiprole Medocaril Sodium
6. N99027v28j
7. Bal5788-001
8. Ro 65-5788
9. Ro-65-5788
10. Bal-5788
11. Sodium;(6r,7r)-7-[[(2z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl]amino]-3-[(e)-[1-[(3r)-1-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxycarbonyl]pyrrolidin-3-yl]-2-oxopyrrolidin-3-ylidene]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
12. Ceftobiprole Medocaril (usan)
13. Ceftobiprole Medocaril [usan]
14. Ceftobiprole Medocaril Sodium Salt
15. Ro-655788
16. Bal-5788-001
17. Schembl4401305
18. Dtxsid601021562
19. Ceftobiprole Medocaril [usan:inn]
20. Ceftobiprole Medocaril [mart.]
21. Hy-106574a
22. Ceftobiprole Medocaril [ema Epar]
23. Cs-0103172
24. Ceftobiprole Medocaril Sodium [who-dd]
25. Ro-65-5788/001
26. Ceftobiprole Medocaril Sodium Salt [mi]
27. D08886
28. (6r,7r)-7-(((2z)-(5-amino-1,2,4-thiadiazol-3-yl)(hydroxyimino)-acetyl)amino)-3-((e)-((3'r)-1'-(((5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy)carbonyl)-2-oxo(1,3'-bipyrrolidin)-3-ylidene)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid Monosodium Salt
29. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2z)-(5-amino-1,2,4-thiadiazol-3-yl) (hydroxyimino)acetyl)amino)-3-((e)-((3'r)-1'-(((5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy)carbonyl)-2-oxo(1,3'-bipyrrolidin)-3-ylidene)methyl)-8-oxo-, Monosodium Salt, (6r,7r)-
| Molecular Weight | 712.6 g/mol |
|---|---|
| Molecular Formula | C26H25N8NaO11S2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 17 |
| Rotatable Bond Count | 9 |
| Exact Mass | 712.09819027 g/mol |
| Monoisotopic Mass | 712.09819027 g/mol |
| Topological Polar Surface Area | 313 Ų |
| Heavy Atom Count | 48 |
| Formal Charge | 0 |
| Complexity | 1570 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Treatment of pneumonia
Treatment of complicated skin and soft-tissue infections
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
ABOUT THIS PAGE
A N99027V28J manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N99027V28J, including repackagers and relabelers. The FDA regulates N99027V28J manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N99027V28J API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A N99027V28J supplier is an individual or a company that provides N99027V28J active pharmaceutical ingredient (API) or N99027V28J finished formulations upon request. The N99027V28J suppliers may include N99027V28J API manufacturers, exporters, distributors and traders.
N99027V28J Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N99027V28J GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N99027V28J GMP manufacturer or N99027V28J GMP API supplier for your needs.
A N99027V28J CoA (Certificate of Analysis) is a formal document that attests to N99027V28J's compliance with N99027V28J specifications and serves as a tool for batch-level quality control.
N99027V28J CoA mostly includes findings from lab analyses of a specific batch. For each N99027V28J CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N99027V28J may be tested according to a variety of international standards, such as European Pharmacopoeia (N99027V28J EP), N99027V28J JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N99027V28J USP).
LOOKING FOR A SUPPLIER?
